BDBM280405 US10030012, Example 35::ethyl 4-[4-(2- methoxypyridin- 3-yl)piperidin- 1-yl]azepane-1- carboxylate
SMILES: CCOC(=O)N1CCCC(CC1)N1CCC(CC1)c1cccnc1OC
InChI Key: InChIKey=IDDOIYOURRKCMR-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muscarinic acetylcholine receptor M4 (Homo sapiens (Human)) | BDBM280405 (US10030012, Example 35 | ethyl 4-[4-(2- methoxypyr...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) BindingDB Entry DOI: 10.7270/Q2KK9DTW | |||||||||||
More data for this Ligand-Target Pair |